Funding Rounds
Amyl Therapeutics

Amyl Therapeutics Series A (2023, $5M)

Amyl Therapeutics

Therapeutics platform to treat diseases linked to amyloid fibrils.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $5.67M

Raised Date: 2023-07-01

Investors